# Haselmeier licenses Axis-D pen-injector technology to Stevanato Group for diabetes care

Haselmeier and Stevanato Group announced an exclusive agreement to license the Axis-D pen-injector technology and IP for diabetes care. Stevanato Group will manufacture the device at its facilities.

- Type: Partnership
- Announced: 2019-10-07
- Status: announced
- Products: Axis-D pen-injector
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Haselmeier](https://endata.com/companies/42565.md)
- [Stevanato Group](https://endata.com/companies/1686.md) (partner)

## Sources

- [einpresswire.com](https://www.einpresswire.com/article/498523576/haselmeier-signs-an-exclusive-agreement-with-stevanato-group-to-license-axis-d-pen-injector-technology-and-intellectual-property-for-the-therapeutic), 2019-10-07: "We are pleased and proud to have Stevanato Group as our strategic partner for Axis-D in Diabetes."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.